The Personal Care Products Council is eyeing a window for cosmetics oversight reform after mid-term congressional elections, as it has become clear in recent days the policy is unlikely to be included in the US Senate’s FDA user-fee reauthorization legislation, scheduled for a vote by 30 September.
At the PCPC’s Leadership Summit in Washington 29 September, executive vice president, government affairs Karin Ross addressed a deal between US House and Senate committee leaders last week to move forward on user-fee reauthorization without most policy riders, quashing hopes for passage of the Modernization of Cosmetics Regulation Act (MoCRA) as part of the package
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?